Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

NEOSTIGMINE METHYLSULFATE

NEOSTIGMINE METHYLSULFATE

Standard Dose
5MG/10ML(0.5MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview NEOSTIGMINE METHYLSULFATE is listed in Drugs@FDA under application 213244 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient NEOSTIGMINE METHYLSULFATE Form and strength INJECTABLE;INJECTION - 5MG/10ML(0.5MG/ML) Sponsor EUGIA PHARMA Submission history Latest submission status date: 2024-10-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview NEOSTIGMINE METHYLSULFATE is listed in Drugs@FDA under application 213244 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NEOSTIGMINE METHYLSULFATE Form and strength INJECTABLE;INJECTION - 5MG/10ML(0.5MG/ML) Sponsor EUGIA PHARMA Submission history Latest submission status date: 2024-10-25 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.